hsa-mir-549a: Hsa-mir-549a is a microRNA that has been found to be significantly differentially expressed among different groups and is up-regulated [PMC5952410]. It has also been identified as one of the significantly differentially expressed miRNAs in glioblastoma tumor tissue and controls [PMC9737249]. Hsa-mir-549a is included in a miRNA risk score calculation for prognostic purposes [PMC9264898]. It has been found to have target genes identified through small RNA-seq analysis [PMC9264898]. Hsa-mir-549a is one of the candidate miRNAs for gastric cancer diagnosis [PMC7882724]. It has also been shown to be significantly decreased in ME/CFS PBMCs [PMC7005890]. Hsa-mir-549a, along with hsa-miR-548ba and hsa-miR-4521, have been identified as novel miRNAs that are deregulated in certain conditions [PMC8900545]. In the context of miRNA-mRNA interaction networks, hsa-mir-549a has a high degree and may be involved in the pathogenesis of certain diseases, such as Huntington's disease [PMC6102687]. References: [PMC5952410] [PMC9737249] [PMC9264898] [PMC7882724] [PMC7005890] [PMC8900545] [PM6102687]